Concepedia

Nicole Loo

NL

12

Publications

1K

Citations

12

H-Index

2005

Active since

Affiliations

Texas Liver Institute(Current)

The University of Texas MD Anderson Cancer Center

The University of Texas Southwestern Medical Center

Southwestern Medical Center

Michael E. DeBakey VA Medical Center

Nicole Loo is an author at Texas Liver Institute specializing in hepatology, medicine, and pathology.

Top concepts

MedicineHepatologyPathologyPharmacologyHealthLiver PhysiologyLiver TransplantationHepatology InflammationNonalcoholic Fatty Liver DiseaseMetabolic Associated Steatohepatitis

Publications per year

2005–2023

12

Publications

12

Saroglitazar, a PPAR‐α/γ Agonist, for Treatment of NAFLD: A Randomized Controlled Double‐Blind Phase 2 Trial

Samer Gawrieh, Mazen Noureddin, Nicole Loo et al. · Hepatology · 2021 · 335 citations · Full text

Acetyl-CoA Carboxylase Inhibitor GS-0976 for 12 Weeks Reduces Hepatic De Novo Lipogenesis and Steatosis in Patients With Nonalcoholic Steatohepatitis

Eric Lawitz, Angie Coste, Fred Poordad et al. · Clinical Gastroenterology and Hepatology · 2018 · 213 citations

Metabolic Syndrome, Metabolic Associated Steatohepatitis, Hepatology +12

Risk factors for HCC in contemporary cohorts of patients with cirrhosis

Fasiha Kanwal, Saira Khaderi, Amit G. Singal et al. · Hepatology · 2022 · 118 citations · Full text

Biosensor Detection of Botulinum Toxoid A and Staphylococcal Enterotoxin B in Food

Kim E. Sapsford, Chris R. Taitt, Nicole Loo et al. · Applied and Environmental Microbiology · 2005 · 93 citations · Full text

A Phase 2 Double Blinded, Randomized Controlled Trial of Saroglitazar in Patients With Nonalcoholic Steatohepatitis

Mohammad Shadab Siddiqui, Michael O. Idowu, Brian B. Borg et al. · Clinical Gastroenterology and Hepatology · 2020 · 82 citations

Double Blinded, Hepatology, Medicine +8

Rows per page

1–5 of 12